ConductScience.org, home

Paper2902689

In vivo administration of anti-CD3 prevents malignant progressor tumor growth.

Ellenhorn JD and 3 others. Science, 1988. Cited by 113 papers, by iCite.

Cite this record

ConductScience Library. In vivo administration of anti-CD3 prevents malignant progressor tumor growth. Papers, record 2902689. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2902689

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
In vivo administration of anti-CD3 prevents malignant progressor tumor growth.
PubMed
Journal
Science
PubMed
Year
1988
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
113
iCite
Relative citation ratio, by iCite
2.37
iCite
Revised in PubMed
2021-12-03
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ellenhorn JDJ D
2Hirsch RR
3Schreiber HH
4Bluestone JAJ A

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigens, Differentiation, T-LymphocyteMajor topic
Lymphocyte ActivationMajor topic
Neoplasms, ExperimentalMajor topic
Receptors, Antigen, T-CellMajor topic
T-LymphocytesMajor topic
Animals
Antigens, Surface
CD3 Complex
Dose-Response Relationship, Immunologic
Immunosuppression Therapy
Immunotherapy
Lymph Nodes
Mice
Neoplasm Transplantation
Receptors, Interleukin-2
Thy-1 Antigens

Source PubMed

Download CSV of topics

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 113 citations.

PMIDTitleJournalYearIn PapersSource
39345919Drug overdose deaths during prison riots and mental states of prisoners: a case study.Front Psychiatry2024https://conductscience.org/library/papers/39345919PubMed
37724258Therapeutic antibodies for precise cancer immunotherapy: current and future perspectives.Med Rev (2021)2022https://conductscience.org/library/papers/37724258PubMed
36831533Modulating T Cell Responses by Targeting CD3.Cancers (Basel)2023https://conductscience.org/library/papers/36831533PubMed
20068406Preclinical evaluation of light-activatable, bispecific anti-human CD3 antibody conjugates as anti-ovarian cancer therapeutics.MAbs2009https://conductscience.org/library/papers/20068406PubMed
18778286Retinoic acid inhibits in vivo interleukin-2 gene expression and T-cell activation in mice.Immunology2009https://conductscience.org/library/papers/18778286PubMed
11961670Tumor gene therapy by MVA-mediated expression of T-cell-stimulating antibodies.Cancer Gene Ther2002https://conductscience.org/library/papers/11961670PubMed
11371607CD3-mediated activation of tumor-reactive lymphocytes from patients with advanced cancer.Proc Natl Acad Sci U S A2001https://conductscience.org/library/papers/11371607PubMed
9159146A lymphocyte-activating monoclonal antibody induces regression of human tumors in severe combined immunodeficient mice.Proc Natl Acad Sci U S A1997https://conductscience.org/library/papers/9159146PubMed
8608651In vitro T cell unresponsiveness following low-dose injection of anti-CD3 MoAb.Clin Exp Immunol1996https://conductscience.org/library/papers/8608651PubMed
8535054The role of the immune system in anti-tumour responses. Potential for drug therapy.Drugs Aging1995https://conductscience.org/library/papers/8535054PubMed
8514611Effect of accessory cells on stimulation of murine T-cell leukemia with antibodies to the CD3/T cell antigen receptor complex.Jpn J Cancer Res1993https://conductscience.org/library/papers/8514611PubMed
8514380An anti-CD3 monoclonal antibody protects mice against a lethal infection with Listeria monocytogenes through induction of endogenous cytokines.Infect Immun1993https://conductscience.org/library/papers/8514380PubMed
8425213Superantigen-based tumor therapy: in vivo activation of cytotoxic T cells.Cancer Immunol Immunother1993https://conductscience.org/library/papers/8425213PubMed
8299119Poor induction of interleukin-2 receptor expression on CD8bright+ cells in whole blood cell cultures with CD3 mAb. Implications for immunotherapy with CD3 mAb.Cancer Immunol Immunother1994https://conductscience.org/library/papers/8299119PubMed
8124689Colon adenocarcinoma cells inhibit anti-CD3-activated killer cell induction.Cancer Immunol Immunother1994https://conductscience.org/library/papers/8124689PubMed
8058730Immunotherapy with anti-CD3 monoclonal antibodies and recombinant interleukin 2: stimulation of molecular programs of cytotoxic killer cells and induction of tumor regression.Proc Natl Acad Sci U S A1994https://conductscience.org/library/papers/8058730PubMed
7954522The immunobiological effects of interleukin-2 in vivo.Cancer Immunol Immunother1994https://conductscience.org/library/papers/7954522PubMed
7684652Eradication of metastatic tumour cells from lymph nodes by local administration of anti-CD3 antibody.Cancer Immunol Immunother1993https://conductscience.org/library/papers/7684652PubMed
1899481In vivo T-cell activation by staphylococcal enterotoxin B prevents outgrowth of a malignant tumor.Proc Natl Acad Sci U S A1991https://conductscience.org/library/papers/1899481PubMed
1830862Alpha beta T-lymphocyte depleted mice, a model for gamma delta T-lymphocyte functional studies.Immunol Rev1991https://conductscience.org/library/papers/1830862PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2902689

GET https://conductscience.org/api/papers/v1/2902689/authors